BLAINJECTIONINJECTABLEPriority Review
Approved
Sep 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Clinical Trials (1)
US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)
Started Dec 2019
2 enrolled
Hairy Cell Leukemia